BBA

Baker Bros. Advisors Portfolio holdings

AUM $10.3B
1-Year Est. Return 63.34%
This Quarter Est. Return
1 Year Est. Return
+63.34%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$5.06B
AUM Growth
–
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
75
New
Increased
Reduced
Closed

Top Buys

1
+$856M
2
+$608M
3
+$433M
4
GEVA
SYNAGEVA BIOPHARMA CORP COM STK (DE)
GEVA
+$387M
5
ACAD icon
Acadia Pharmaceuticals
ACAD
+$362M

Top Sells

No sells this quarter

Sector Composition

1 Healthcare 39.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
1
$856M 16.93%
+10,771,138
2
$608M 12.02%
+19,322,947
3
$433M 8.56%
+13,650,835
4
$387M 7.66%
+9,223,182
5
$362M 7.16%
+19,955,126
6
$326M 6.44%
+14,810,559
7
$244M 4.83%
+8,528,603
8
$73.6M 1.46%
+1,013,729
9
$63.9M 1.26%
+1,245,800
10
$58.5M 1.16%
+924,343
11
$52.1M 1.03%
+6,553,150
12
$51.3M 1.01%
+2,778,654
13
$43.7M 0.86%
+783,311
14
$37.4M 0.74%
+8,455,306
15
$35.2M 0.7%
+525,113
16
$32M 0.63%
+3,966,179
17
$25.4M 0.5%
+1,450,000
18
$21.5M 0.42%
+900,000
19
$20.8M 0.41%
+462,847
20
$19.6M 0.39%
+796,662
21
$18.7M 0.37%
+4,200,000
22
$18.1M 0.36%
+1,358,857
23
$16.5M 0.33%
+3,578,591
24
$16.5M 0.33%
+1,016,433
25
$14.4M 0.28%
+315,846
1
2 3